PI 3-kinase p85γ Activators refers to a class of chemical compounds that possess the unique ability to interact with and modulate the activity of the regulatory subunit p85γ of phosphoinositide 3-kinase (PI 3-kinase). PI 3-kinases are a family of lipid kinases that play a central role in cell signaling pathways involved in cell growth, proliferation, survival, and metabolism. They function by phosphorylating phosphoinositides at the 3-position of the inositol ring, generating important secondary messengers that regulate various cellular processes. The p85γ regulatory subunit of PI 3-kinase serves as an adapter molecule that binds to and regulates the catalytic subunit of PI 3-kinase, influencing its activity and substrate specificity. PI 3-kinase p85γ activators are compounds that can interact with p85γ and modulate its role in PI 3-kinase signaling.
The mechanism of action of PI 3-kinase p85γ activators typically involves their capacity to enhance or inhibit the binding of p85γ to the catalytic subunit of PI 3-kinase. This interaction between p85γ and the catalytic subunit is crucial for the activation and regulation of PI 3-kinase. Activators may influence the conformation or stability of the p85γ-catalytic subunit complex, affecting the kinase's ability to phosphorylate phosphoinositides and propagate downstream signaling. Additionally, these compounds may impact the recruitment of PI 3-kinase to cellular membranes, where it encounters its lipid substrates. Understanding the properties and effects of PI 3-kinase p85γ activators is essential for elucidating the complex signaling networks in which PI 3-kinase is involved, as well as the mechanisms that govern cellular responses to growth factors, cytokines, and other extracellular signals. It provides insights into the regulatory mechanisms that control PI 3-kinase function and its role in diverse physiological and pathological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin indirectly activates PI 3-kinase p85γ by binding to insulin receptors, triggering a signaling cascade that leads to PI3K activation. | ||||||
PX-866 | 502632-66-8 | sc-396764 sc-396764A | 1 mg 5 mg | $149.00 $288.00 | ||
Sonolisib indirectly activates PI 3-kinase p85γ by inhibiting PTEN, a negative regulator of the PI3K pathway. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Triciribine, by inhibiting Akt, can lead to compensatory activation of the PI3K pathway, indirectly affecting p85γ. | ||||||